Resumen
Low diastolic blood pressure is alleged to impose excess cardiovascular disease (CVD) risk in patients with treated hypertension, impeding aggressive reduction of blood pressure. Most investigations that assessed the potential J-shaped relations of diastolic blood pressure and adverse outcomes have not adequately considered systolic or pulse pressure in statistical analyses. An overview of hypertension trials indicates that lowering elevated blood pressure reduces the risk of CVD outcomes irrespective of the associated decrease in diastolic pressure, even if the achieved diastolic pressure averages less than 70 mm Hg. The Framingham study investigations have determined that the increased CVD incidence observed at low diastolic blood pressure levels is confined largely to persons with concomitantly increased systolic pressure. This finding of no true excess risk at low diastolic blood pressure agrees with the results of trials that have evaluated the J-curve phenomenon adjusting for systolic pressure. Aggressively treating systolic hypertension appears to produce no cause for alarm.
| Idioma original | English (US) |
|---|---|
| Páginas (desde-hasta) | 204-208 |
| Número de páginas | 5 |
| Publicación | Current Cardiovascular Risk Reports |
| Volumen | 1 |
| N.º | 3 |
| DOI | |
| Estado | Published - 2007 |
| Publicado de forma externa | Sí |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
Huella
Profundice en los temas de investigación de 'The J-curve relationship of treated diastolic blood pressure to mortality risk: Is it real? Is it clinically meaningful?'. En conjunto forman una huella única.Citar esto
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS